Literature DB >> 16125456

PCR detection of viral DNA in serum as an ancillary analysis for the diagnosis of acute mononucleosis-like syndrome due to human cytomegalovirus (HCMV) in immunocompetent patients.

David Navalpotro1, Concepción Gimeno, David Navarro.   

Abstract

BACKGROUND: Serologic tests are occasionally inconclusive for the diagnosis of mononucleosis-like syndrome due to human cytomegalovirus (HCMV).
OBJECTIVES: To determine the value of viral DNA detection in serum by PCR as an ancillary test for the diagnosis of HCMV mononucleosis. STUDY
DESIGN: Sera from 34 previously healthy individuals with HCMV mononucleosis, obtained within 1 month after the onset of symptoms, were assayed for viral DNA by three commercial PCRs (QCA gB, QCA MIE and Amplicor CMV Monitor). Sera from 30 patients with evidence of past HCMV infection served as controls.
RESULTS: Viral DNA was detected in 20% of the samples from patients with HCMV mononucleosis by both QCA procedures, but in none of the controls. All samples tested negative by the Amplicor CMV Monitor.
CONCLUSION: Analysis of sera for the presence of HCMV DNA is of limited value for the diagnosis of HCMV mononucleosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125456     DOI: 10.1016/j.jcv.2005.07.008

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  3 in total

1.  The Brief Case: Nystagmus in a 3-Month-Old Leading to a Diagnosis of Congenital Cytomegalovirus Infection.

Authors:  Priyanka Uprety; Erin H Graf
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

2.  Evaluation of a standardised real-time PCR based DNA-detection method (Realstar®) in whole blood for the diagnosis of primary human cytomegalovirus (CMV) infections in immunocompetent patients.

Authors:  M Berth; I Benoy; N Christensen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-10       Impact factor: 3.267

3.  Cytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease.

Authors:  Tobias M Nowacki; Dominik Bettenworth; Matthias Ross; Jan Heidemann; Paul V Lehmann; Andreas Lügering
Journal:  Cells       Date:  2012-04-23       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.